Amy W Schulman is Director of SQZ Biotechnologies Co. Currently has a direct ownership of 214,814 shares of SQZ, which is worth approximately $10,740. The most recent transaction as insider was on Dec 22, 2021, when has been sold 24,130 shares (Common Stock) at a price of $3.73 per share, resulting in proceeds of $90,005. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 215K
0% 3M change
0% 12M change
Total Value Held $10,740

AMY W SCHULMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2021
BUY
Exercise of conversion of derivative security
$90,005 $3.73 p/Share
24,130 Added 10.1%
214,814 Common Stock
Nov 03 2020
BUY
Conversion of derivative security
-
22,204 Added 10.43%
190,684 Common Stock

Also insider at

ALNY
ALNYLAM PHARMACEUTICALS, INC. Healthcare
HCIIW
Hudson Executive Investment Corp. II ETFs
GUTS
Fractyl Health, Inc.
AWS

Amy W Schulman

Director
Cambridge, MA

Track Institutional and Insider Activities on SQZ

Follow SQZ Biotechnologies Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SQZ shares.

Notify only if

Insider Trading

Get notified when an Sqz Biotechnologies CO insider buys or sells SQZ shares.

Notify only if

News

Receive news related to SQZ Biotechnologies Co

Track Activities on SQZ